Pfizer Limited
Pfizer Limited (PFIZER.NS) Stock Competitors & Peer Comparison
See (PFIZER.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PFIZER.NS | ₹5,084.50 | -1.20% | 232.9B | 27.28 | ₹186.63 | +3.21% |
| CIPLA.NS | ₹1,326.70 | -1.44% | 1.1T | 24.14 | ₹56.25 | +1.19% |
| CIPLA.BO | ₹1,326.30 | -1.44% | 1.1T | 24.16 | ₹56.20 | +1.19% |
| ABBOTINDIA.NS | ₹26,365.00 | -0.17% | 560B | 36.75 | ₹717.13 | +1.80% |
| ABBOTINDIA.BO | ₹26,342.90 | -0.27% | 559.6B | 37.07 | ₹710.49 | +1.80% |
| GLAXO.NS | ₹2,618.20 | -1.29% | 444.9B | 43.65 | ₹60.16 | +2.04% |
| GLAXO.BO | ₹2,619.40 | -1.19% | 444.7B | 46.62 | ₹56.30 | +2.04% |
| GLAND.BO | ₹1,801.30 | -2.40% | 307.6B | 36.37 | ₹51.34 | +0.97% |
| GLAND.NS | ₹1,802.40 | -2.49% | 306.6B | 36.23 | ₹51.37 | +0.97% |
| PFIZER.BO | ₹5,086.55 | -1.12% | 233B | 27.78 | ₹183.33 | +3.21% |
Stock Comparison
PFIZER.NS vs CIPLA.NS Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, CIPLA.NS has a market cap of 1.1T. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while CIPLA.NS trades at ₹1,326.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas CIPLA.NS's P/E ratio is 24.14. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to CIPLA.NS's ROE of +0.15%. Regarding short-term risk, PFIZER.NS is more volatile compared to CIPLA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PFIZER.NS.Check CIPLA.NS's competition here
PFIZER.NS vs CIPLA.BO Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, CIPLA.BO has a market cap of 1.1T. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while CIPLA.BO trades at ₹1,326.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas CIPLA.BO's P/E ratio is 24.16. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to CIPLA.BO's ROE of +0.15%. Regarding short-term risk, PFIZER.NS is more volatile compared to CIPLA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PFIZER.NS.Check CIPLA.BO's competition here
PFIZER.NS vs ABBOTINDIA.NS Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, ABBOTINDIA.NS has a market cap of 560B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while ABBOTINDIA.NS trades at ₹26,365.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas ABBOTINDIA.NS's P/E ratio is 36.75. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to ABBOTINDIA.NS's ROE of +0.38%. Regarding short-term risk, PFIZER.NS is more volatile compared to ABBOTINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PFIZER.NS.Check ABBOTINDIA.NS's competition here
PFIZER.NS vs ABBOTINDIA.BO Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, ABBOTINDIA.BO has a market cap of 559.6B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while ABBOTINDIA.BO trades at ₹26,342.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas ABBOTINDIA.BO's P/E ratio is 37.07. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to ABBOTINDIA.BO's ROE of +0.38%. Regarding short-term risk, PFIZER.NS is more volatile compared to ABBOTINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PFIZER.NS.Check ABBOTINDIA.BO's competition here
PFIZER.NS vs GLAXO.NS Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, GLAXO.NS has a market cap of 444.9B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while GLAXO.NS trades at ₹2,618.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas GLAXO.NS's P/E ratio is 43.65. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to GLAXO.NS's ROE of +0.56%. Regarding short-term risk, PFIZER.NS is more volatile compared to GLAXO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PFIZER.NS.Check GLAXO.NS's competition here
PFIZER.NS vs GLAXO.BO Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, GLAXO.BO has a market cap of 444.7B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while GLAXO.BO trades at ₹2,619.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas GLAXO.BO's P/E ratio is 46.62. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to GLAXO.BO's ROE of +0.56%. Regarding short-term risk, PFIZER.NS is less volatile compared to GLAXO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PFIZER.NS.Check GLAXO.BO's competition here
PFIZER.NS vs GLAND.BO Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, GLAND.BO has a market cap of 307.6B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while GLAND.BO trades at ₹1,801.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas GLAND.BO's P/E ratio is 36.37. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to GLAND.BO's ROE of +0.09%. Regarding short-term risk, PFIZER.NS is more volatile compared to GLAND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PFIZER.NS.Check GLAND.BO's competition here
PFIZER.NS vs GLAND.NS Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, GLAND.NS has a market cap of 306.6B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while GLAND.NS trades at ₹1,802.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas GLAND.NS's P/E ratio is 36.23. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to GLAND.NS's ROE of +0.09%. Regarding short-term risk, PFIZER.NS is more volatile compared to GLAND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PFIZER.NS.Check GLAND.NS's competition here
PFIZER.NS vs PFIZER.BO Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, PFIZER.BO has a market cap of 233B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while PFIZER.BO trades at ₹5,086.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas PFIZER.BO's P/E ratio is 27.78. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to PFIZER.BO's ROE of +0.21%. Regarding short-term risk, PFIZER.NS is more volatile compared to PFIZER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PFIZER.NS.Check PFIZER.BO's competition here
PFIZER.NS vs SANOFICONR.NS Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, SANOFICONR.NS has a market cap of 105.1B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while SANOFICONR.NS trades at ₹3,999.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas SANOFICONR.NS's P/E ratio is 48.24. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to SANOFICONR.NS's ROE of +0.82%. Regarding short-term risk, PFIZER.NS is less volatile compared to SANOFICONR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PFIZER.NS.Check SANOFICONR.NS's competition here
PFIZER.NS vs SANOFI.NS Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, SANOFI.NS has a market cap of 92.5B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while SANOFI.NS trades at ₹4,080.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas SANOFI.NS's P/E ratio is 25.97. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to SANOFI.NS's ROE of +0.42%. Regarding short-term risk, PFIZER.NS is more volatile compared to SANOFI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PFIZER.NS.Check SANOFI.NS's competition here
PFIZER.NS vs SANOFI.BO Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, SANOFI.BO has a market cap of 92.5B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while SANOFI.BO trades at ₹4,077.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas SANOFI.BO's P/E ratio is 25.94. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to SANOFI.BO's ROE of +0.42%. Regarding short-term risk, PFIZER.NS is more volatile compared to SANOFI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for PFIZER.NS.Check SANOFI.BO's competition here
PFIZER.NS vs MARKSANS.NS Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, MARKSANS.NS has a market cap of 80.1B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while MARKSANS.NS trades at ₹174.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas MARKSANS.NS's P/E ratio is 22.27. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to MARKSANS.NS's ROE of +0.14%. Regarding short-term risk, PFIZER.NS is less volatile compared to MARKSANS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PFIZER.NS.Check MARKSANS.NS's competition here
PFIZER.NS vs MARKSANS.BO Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, MARKSANS.BO has a market cap of 80B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while MARKSANS.BO trades at ₹174.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas MARKSANS.BO's P/E ratio is 22.75. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to MARKSANS.BO's ROE of +0.14%. Regarding short-term risk, PFIZER.NS is less volatile compared to MARKSANS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PFIZER.NS.Check MARKSANS.BO's competition here
PFIZER.NS vs SMSPHARMA.BO Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, SMSPHARMA.BO has a market cap of 36.5B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while SMSPHARMA.BO trades at ₹380.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas SMSPHARMA.BO's P/E ratio is 38.82. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to SMSPHARMA.BO's ROE of +0.14%. Regarding short-term risk, PFIZER.NS is less volatile compared to SMSPHARMA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PFIZER.NS.Check SMSPHARMA.BO's competition here
PFIZER.NS vs SMSPHARMA.NS Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, SMSPHARMA.NS has a market cap of 36.5B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while SMSPHARMA.NS trades at ₹380.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas SMSPHARMA.NS's P/E ratio is 38.86. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to SMSPHARMA.NS's ROE of +0.14%. Regarding short-term risk, PFIZER.NS is less volatile compared to SMSPHARMA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PFIZER.NS.Check SMSPHARMA.NS's competition here
PFIZER.NS vs SENORES.NS Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, SENORES.NS has a market cap of 35.7B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while SENORES.NS trades at ₹779.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas SENORES.NS's P/E ratio is 30.11. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to SENORES.NS's ROE of +0.13%. Regarding short-term risk, PFIZER.NS is less volatile compared to SENORES.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PFIZER.NS.Check SENORES.NS's competition here
PFIZER.NS vs NGLFINE.NS Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, NGLFINE.NS has a market cap of 14.2B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while NGLFINE.NS trades at ₹2,254.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas NGLFINE.NS's P/E ratio is 40.31. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to NGLFINE.NS's ROE of +0.12%. Regarding short-term risk, PFIZER.NS is less volatile compared to NGLFINE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PFIZER.NS.Check NGLFINE.NS's competition here
PFIZER.NS vs NGLFINE.BO Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, NGLFINE.BO has a market cap of 14.2B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while NGLFINE.BO trades at ₹2,246.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas NGLFINE.BO's P/E ratio is 40.10. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to NGLFINE.BO's ROE of +0.12%. Regarding short-term risk, PFIZER.NS is less volatile compared to NGLFINE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PFIZER.NS.Check NGLFINE.BO's competition here
PFIZER.NS vs TTKHLTCARE.NS Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, TTKHLTCARE.NS has a market cap of 12.9B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while TTKHLTCARE.NS trades at ₹916.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas TTKHLTCARE.NS's P/E ratio is 21.58. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to TTKHLTCARE.NS's ROE of +0.06%. Regarding short-term risk, PFIZER.NS is more volatile compared to TTKHLTCARE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for PFIZER.NS.Check TTKHLTCARE.NS's competition here
PFIZER.NS vs KOPRAN.NS Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, KOPRAN.NS has a market cap of 6.4B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while KOPRAN.NS trades at ₹128.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas KOPRAN.NS's P/E ratio is 39.01. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to KOPRAN.NS's ROE of +0.03%. Regarding short-term risk, PFIZER.NS is less volatile compared to KOPRAN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for PFIZER.NS.Check KOPRAN.NS's competition here
PFIZER.NS vs KOPRAN.BO Comparison February 2026
PFIZER.NS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PFIZER.NS stands at 232.9B. In comparison, KOPRAN.BO has a market cap of 6.4B. Regarding current trading prices, PFIZER.NS is priced at ₹5,084.50, while KOPRAN.BO trades at ₹128.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PFIZER.NS currently has a P/E ratio of 27.28, whereas KOPRAN.BO's P/E ratio is 38.93. In terms of profitability, PFIZER.NS's ROE is +0.21%, compared to KOPRAN.BO's ROE of +0.03%. Regarding short-term risk, PFIZER.NS is less volatile compared to KOPRAN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for PFIZER.NS.Check KOPRAN.BO's competition here